Ferrer selects new compound for clinical development as atypical antipsychotic Jan. 21, 1999 No Comments
Dopaminergic compound evaluated in small group of PD patients; no evidence of efficacy Jan. 21, 1999 No Comments
Wyeth-Ayerst's nonbenzodiazepine hypnotic zaleplon considered approvable by the FDA Jan. 21, 1999 No Comments
RSS